Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study

Beste, 2015, Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013, Gastroenterology, 149, 1471, 10.1053/j.gastro.2015.07.056 D'Amico, 2006, Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies, J Hepatol, 44, 217, 10.1016/j.jhep.2005.10.013 Hytiroglou, 2012, Beyond “cirrhosis”: a proposal from the International Liver Pathology Study Group, Am J Clin Pathol, 137, 5, 10.1309/AJCP2T2OHTAPBTMP Ripoll, 2007, Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis, Gastroenterology, 133, 481, 10.1053/j.gastro.2007.05.024 Kim, 2008, Hyponatremia and mortality among patients on the liver-transplant waiting list, N Engl J Med, 359, 1018, 10.1056/NEJMoa0801209 Child, 1964, Surgery and portal hypertension, Major Probl Clin Surg, 1, 1 Durand, 2014, Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography, J Hepatol, 60, 1151, 10.1016/j.jhep.2014.02.026 Englesbe, 2010, Sarcopenia and mortality after liver transplantation, J Am Coll Surg, 211, 271, 10.1016/j.jamcollsurg.2010.03.039 Sharma, 2016, Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients, Liver Transpl, 22, 1092, 10.1002/lt.24458 Montano-Loza, 2014, Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation, Curr Opin Clin Nutr Metab Care, 17, 219, 10.1097/MCO.0000000000000046 Montano-Loza, 2012, Muscle wasting is associated with mortality in patients with cirrhosis, Clin Gastroenterol Hepatol, 10, 166, 10.1016/j.cgh.2011.08.028 Englesbe, 2012, Quantifying the eyeball test: sarcopenia, analytic morphomics, and liver transplantation, Liver Transpl, 18, 1136, 10.1002/lt.23510 Terjimanian, 2016, Abdominal adiposity, body composition and survival after liver transplantation, Clin Transplant, 30, 289, 10.1111/ctr.12688 Ioannou, 2003, Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study, Gastroenterology, 125, 1053, 10.1016/S0016-5085(03)01200-9 Charlton, 2006, Impact of obesity on treatment of chronic hepatitis C, Hepatology, 43, 1177, 10.1002/hep.21239 Hart, 2010, Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies, BMJ, 340, c1240, 10.1136/bmj.c1240 Berzigotti, 2011, Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis, Hepatology, 54, 555, 10.1002/hep.24418 Aberra, 2013, Quality improvement measures lead to higher surveillance rates for hepatocellular carcinoma in patients with cirrhosis, Dig Dis Sci, 58, 1157, 10.1007/s10620-012-2461-4 Englesbe, 2012, Analytic morphomics, core muscle size, and surgical outcomes, Ann Surg, 256, 255, 10.1097/SLA.0b013e31826028b1 Krishnamurthy, 2015, Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis, Clin Gastroenterol Hepatol, 13, 360, 10.1016/j.cgh.2014.07.042 Singal, 2016, Body composition features predict overall survival in patients with hepatocellular carcinoma, Clin Transl Gastroenterol, 7, e172, 10.1038/ctg.2016.31 Goodpaster, 1999, Effects of weight loss on regional fat distribution and insulin sensitivity in obesity, Diabetes, 48, 839, 10.2337/diabetes.48.4.839 Wang, 2016, 582 Venables, 2002 Rahman, 2017, Review and evaluation of performance measures for survival prediction models in external validation settings, BMC Med Res Methodol, 17, 60, 10.1186/s12874-017-0336-2 Pencina, 2011, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers, Stat Med, 30, 11, 10.1002/sim.4085 Uno, 2013, A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data, Stat Med, 32, 2430, 10.1002/sim.5647 Heller, 2016, Estimating the concordance probability in a survival analysis with a discrete number of risk groups, Lifetime Data Anal, 22, 263, 10.1007/s10985-015-9330-3 Royston, 2004, A new measure of prognostic separation in survival data, Stat Med, 23, 723, 10.1002/sim.1621 Hosmer, 1997, A comparison of goodness-of-fit tests for the logistic regression model, Stat Med, 16, 965, 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O Graf, 1999, Assessment and comparison of prognostic classification schemes for survival data, Stat Med, 18, 2529, 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529::AID-SIM274>3.0.CO;2-5 Fine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, 94, 496, 10.1080/01621459.1999.10474144 Ripoll, 2005, Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era, Hepatology, 42, 793, 10.1002/hep.20871 Everson, 2012, Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C antiviral long-term treatment against cirrhosis trial, Hepatology, 55, 1019, 10.1002/hep.24752 Thandassery, 2016, Role of nutrition and muscle in cirrhosis, Curr Treat Options Gastroenterol, 14, 257, 10.1007/s11938-016-0093-z Tandon, 2016, A model to identify sarcopenia in patients with cirrhosis, Clin Gastroenterol Hepatol, 14, 1473, 10.1016/j.cgh.2016.04.040 Tandon, 2012, Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value, Liver Transpl, 18, 1209, 10.1002/lt.23495 Tapper, 2016, Does Karnofsky performance status of patients with cirrhosis on the transplant waitlist meet the eyeball test?, Clin Gastroenterol Hepatol, 14, 1196, 10.1016/j.cgh.2016.04.024 Montano-Loza, 2015, Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis, Clin Transl Gastroenterol, 6, e102, 10.1038/ctg.2015.31 Yadav, 2015, Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates, Clin Transplant, 29, 134, 10.1111/ctr.12493 Ebadi, 2018, Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis, J Hepatol, 69, 608, 10.1016/j.jhep.2018.04.015 Montano-Loza, 2014, Skeletal muscle abnormalities and outcomes after liver transplantation, Liver Transpl, 20, 1293, 10.1002/lt.23995 Derstine, 2017, Quantifying sarcopenia reference values using lumbar and thoracic muscle areas in a healthy population, J Nutr Health Aging, 21, 180 Derstine, 2018, Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population, Sci Rep, 8, 11369, 10.1038/s41598-018-29825-5 Lee, 2014, Dorsal muscle group area and surgical outcomes in liver transplantation, Clin Transplant, 28, 1092, 10.1111/ctr.12422 Kumar, 2017, Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis, Hepatology, 65, 2045, 10.1002/hep.29107 Montano-Loza, 2018, Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant, Hepatology, 67, 914, 10.1002/hep.29578 Murphy, 2014, Adipose tissue density, a novel biomarker predicting mortality risk in older adults, J Gerontol A Biol Sci Med Sci, 69, 109, 10.1093/gerona/glt070